Oral triple therapy cuts bad cholesterol by 65%, says cardiologist
Cardiology professor Khaled Al-Nemer says oral triple therapy reduces LDL cholesterol by 65%, outperforming cholesterol injections.
Key Takeaways
AIKhaled Al-Nemer, professor and consultant of cardiology and arterial catheterization at the College of Medicine, said that oral triple therapy for cholesterol—combining rosuvastatin, ezetimibe, and bempedoic acid—reduces bad cholesterol by 65% according to comparative studies.
Al-Nemer noted on his X account that this effect is slightly greater than that of cholesterol injections alone, which lower bad cholesterol by 55%.
He added that the oral therapy is less expensive, easier to use, and does not require injections.